Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
2.000
+0.250 (14.29%)
Mar 9, 2026, 9:49 AM EST
Silence Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 11.28 | 121.33 | 68.79 | 66.05 | 99.57 | Upgrade
|
| Short-Term Investments | 73.84 | 26 | - | 19.67 | - | Upgrade
|
| Cash & Short-Term Investments | 85.11 | 147.33 | 68.79 | 85.72 | 99.57 | Upgrade
|
| Cash Growth | -42.23% | 114.18% | -19.75% | -13.91% | 94.75% | Upgrade
|
| Accounts Receivable | - | 0.97 | 0.29 | 1.1 | 0.45 | Upgrade
|
| Other Receivables | 24.61 | 25.94 | 23.69 | 19.79 | 11.04 | Upgrade
|
| Receivables | 24.61 | 26.91 | 23.98 | 20.9 | 11.49 | Upgrade
|
| Prepaid Expenses | 8.93 | 13.12 | 10.39 | 9.88 | 5.83 | Upgrade
|
| Total Current Assets | 118.66 | 187.37 | 103.15 | 116.5 | 116.9 | Upgrade
|
| Property, Plant & Equipment | 1.75 | 1.98 | 2.31 | 2.65 | 2.63 | Upgrade
|
| Long-Term Investments | - | - | - | 0.34 | 0.41 | Upgrade
|
| Goodwill | 10.62 | 9.39 | 9.98 | 9.65 | 10.28 | Upgrade
|
| Other Intangible Assets | 0.29 | 0.31 | 0.36 | 0.39 | 0.03 | Upgrade
|
| Other Long-Term Assets | 0.13 | 3.59 | 3.65 | - | - | Upgrade
|
| Total Assets | 131.44 | 202.64 | 119.45 | 129.53 | 130.25 | Upgrade
|
| Accounts Payable | 4.41 | 3.7 | 3.35 | 3.84 | 5.5 | Upgrade
|
| Accrued Expenses | 8.91 | 12.05 | 11.72 | 10.67 | 8.85 | Upgrade
|
| Current Portion of Leases | 0.09 | 0.12 | 0.23 | 0.54 | 0.19 | Upgrade
|
| Current Income Taxes Payable | 0.04 | 0.65 | 0.47 | 0.71 | 0.25 | Upgrade
|
| Current Unearned Revenue | 0.17 | 0.31 | 6.57 | 10.68 | 5.75 | Upgrade
|
| Total Current Liabilities | 13.61 | 16.82 | 22.34 | 26.44 | 20.54 | Upgrade
|
| Long-Term Leases | 0.07 | - | 0.12 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 55.45 | 51.79 | 75 | 76.49 | 98.17 | Upgrade
|
| Total Liabilities | 69.14 | 68.61 | 97.46 | 102.93 | 118.71 | Upgrade
|
| Common Stock | 10.29 | 10.29 | 8.85 | 6.49 | 6.08 | Upgrade
|
| Additional Paid-In Capital | 617.56 | 609.56 | 455.77 | 273.11 | 249.6 | Upgrade
|
| Retained Earnings | -562.57 | -474.04 | -431.89 | -317.2 | -301.91 | Upgrade
|
| Comprehensive Income & Other | -2.98 | -11.78 | -10.73 | 64.19 | 57.78 | Upgrade
|
| Shareholders' Equity | 62.3 | 134.02 | 21.99 | 26.59 | 11.54 | Upgrade
|
| Total Liabilities & Equity | 131.44 | 202.64 | 119.45 | 129.53 | 130.25 | Upgrade
|
| Total Debt | 0.16 | 0.12 | 0.35 | 0.54 | 0.19 | Upgrade
|
| Net Cash (Debt) | 84.95 | 147.22 | 68.44 | 85.18 | 99.39 | Upgrade
|
| Net Cash Growth | -42.29% | 115.09% | -19.65% | -14.29% | 96.17% | Upgrade
|
| Net Cash Per Share | 1.80 | 3.18 | 1.85 | 2.65 | 3.35 | Upgrade
|
| Filing Date Shares Outstanding | 47.23 | 47.22 | 46.5 | 35.95 | 29.93 | Upgrade
|
| Total Common Shares Outstanding | 47.23 | 47.22 | 39.62 | 35.94 | 29.93 | Upgrade
|
| Working Capital | 105.05 | 170.54 | 80.82 | 90.06 | 96.36 | Upgrade
|
| Book Value Per Share | 1.32 | 2.84 | 0.56 | 0.74 | 0.39 | Upgrade
|
| Tangible Book Value | 51.4 | 124.32 | 11.65 | 16.56 | 1.23 | Upgrade
|
| Tangible Book Value Per Share | 1.09 | 2.63 | 0.29 | 0.46 | 0.04 | Upgrade
|
| Machinery | 5.54 | 6.34 | 6.44 | 6.01 | 6.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.